To further evaluate the clinical usefulness of serum neopterin measurement as a parameter monitoring disease activity in children with ulcerative colitis, serum neopterin concentrations were evaluated using immunoenzyme assay (ELISA) in 48 patients suffering from ulcerative colitis with different disease activity. Statistically significant differences in serum neopterin concentration depending on disease activity (according to Truelove-Witts score) as well as statistically significant positive correlation between these variables were observed. We conclude that serum neopterin measurement can be clinically valuable as the parameter monitoring disease activity in children with ulcerative colitis.
Introduction
At the beginning of the eighties of the 20 th century, pteridine derivative neopterin was described as biochemical indicator of cell-mediated immune response (1) . It was proved that activated T lymphocytes secrete γ-interferon stimulating monocytes/macrophages to release neopterin (2) . Defining autoimmunization phenomenon, we consider reactivity of cells that belong to adaptive immunity system (immunocompetent lymphocytes T and B), directed against specific antigens of the organism. Participation of cell-mediated immunity in autoimmune diseases permits to expect increased neopterin concentration in patient's systemic fluids. Neopterin concentration was assessed in patients with rheumatoid arthritis (3, 4) , systemic lupus erythematosus (5, 6) , Wegener granuloma (7), polymyositis, and dermatomyositis (8) . Considering above mentioned diseases, neopterin concentration increased in accordance with degree of disease progression. On the base of these observations, assessment of neopterin concentration is described as sensitive parameter in disease clinical course monitoring, but authors greatly emphasize shortage of test specificity. Analysis of neopterin concentration in systemic fluids also permits to monitor activity of inflammatory bowel diseases (IBD), including Crohn's disease (9, 10) . Observations regarding alterations of neopterin concentrations contributed to better knowledge concerning etiopathogenesis of this disease and immune system participation. Similarly, usefulness of neopterin concentrations was assessed in monitoring disease activity in patients with diagnosed ulcerative colitis (11) .
The aim of the study is to evaluate clinical usefulness of serum neopterin measurement as a parameter monitoring disease activity in children with ulcerative colitis.
Materials and Methods
Forty eight patients suffering from ulcerative colitis with different disease severity entered the study. These children were diagnosed and treated in the Chair In the study group an extra 50 µl of blood was taken for determination of serum neopterin concentration. The blood samplings were carefully protected from sunlight, then in less than 20 minutes after collection they were centrifuged at 3,000 rpm for 10 minutes. The obtained serum was frozen at -20°C. Measurement of serum neopterin concentration was performed using immunoenzyme assay (ELISA) commercial kit by BRAHMS Corporation, Hennigsdorf/Berlin, Germany, for quantitative measurement of serum neopterin concentrations. This test uses technique of covered plates.
In all the patients the diagnosis of the active stage of ulcerative colitis was confirmed by endoscopic and histological changes. None of the children was treated with steroids, immunosuppressive or immunomodulatory therapy during the 3 months before the study.
The results of the study were analyzed statistically using Statistica 7.0 (StatSoft, Inc., Tulsa, OK., USA). The correlation of parameters was analyzed by Spearmann test and differences among groups of unpaired data by distribution-free Mann-Whitney test. A p-value of <0.05 was regarded as statistically significant.
All tests were performed in children with written consent of their parents/legal tutors who were informed about the aim and assumptions of the study. The consent of Independent Bioethical Committee for Scientific Research of the Medical University of Gdansk was obtained to perform these studies (NKEBN/942/2004).
Results
Forty-eight patients suffering from ulcerative colitis formed a group including 16 (33%) girls and 32 (67%) boys, at the age from 3.9 to 17.8 years (mean 13.5 ±4.0 years, median 15.4 years). Urea and creatinine concentrations were within the normal for age values in all the children.
Serum neopterin concentration in the study group was within the limits from 3.44 to 26.1 nmol/L (mean 8.76 ± 5.57 nmol/L, median 6.89 nmol/L). In children with ulcerative colitis statistically significant positive correlation was observed between serum neopterin concentration and: body temperature (rs = 0.33, p = 0.02), erythrocyte sedimentation rate (rs = 0.65, p <0.001) (Figure 1 ), serum C-reactive proteine concentration (rs = 0.59, p <0.001) (Figure 2) , and leukocytes count (rs = 0.44, p = 0.002). There were no statistically significant correlation between serum neopterin concentration and serum procalcitonin concentration (rs = 0.24, p = 0.10).
Disease activity in children with ulcerative colitis was assessed on the basis of commonly used TrueloveWitts score modified by Polish authors (12) . In 30 children low activity, in 12 moderate, and in 6 severe activity of the disease was evaluated. Serum neopterin concentration was statistically significantly higher in children with severe than with moderate activity of the disease (p = 0.01) and the concentration in patients with moderate activity was also significantly higher than in patients with mild activity of ulcerative colitis (p = 0.04) ( Table 1) . Statistically significant positive correlation between serum neopterin concentration and the activity of the disease were observed (rs = 0.64; p <0.001). 
Discussion
Literature data indicate that multiple attempts were undertaken to explore clinical usefulness of neopterin concentration measurement in autoimmune diseases (13) (14) (15) . It is generally known that cell-mediated immune response participates in etiopathogenesis of this group of diseases (16) . It was noted that neopterin concentration reflects activity and progression of autoimmune diseases (17) . Above mentioned reports assessed neopterin concentration mainly in adults, but only in few cases they concern childhood diseases.
Studies included for example children suffering from celiac disease, in whom significantly higher neopterin concentrations were observed during active disease, but gluten-free diet administration caused systematic decrease of urine neopterin concentration (13) .
Studies performed among children with juvenile form of dermatomyositis (at the age of 4-17 years) revealed that their urine neopterin concentration considerably correlates with disease activity, muscles function and allows to predict further course of the disease. Correlation between neopterin concentration and concentrations of the enzymes lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) was not found. LDH and AST are usually increased in patients with juvenile form of dermatomyositis (18) .
There are relatively few reports in world literature concerning clinical usefulness of neopterin concentration measurement in inflammatory bowel diseases. Studies were predominantly performed in adults (9, 10, 19) and only one case concerns children with Crohn's disease (20) . Urine neopterin concentration was measured in majority of studies (9, 10, 21) . There are only single reports about serum neopterin concentration in IBD patients (7, 22, 23) . No publication concerning this subject was found in local literature. According to known reports, increased neopterin concentration is observed in majority of patients with active form of IBD (Crohn's disease, ulcerative colitis). Almost all authors greatly emphasize lack of specificity of this marker besides noted positive correlations between neopterin concentration in systemic fluids and activity of Crohn's disease or ulcerative colitis. Authors consider that neopterin concentration monitoring is recommended parallel to observations concerning number of other laboratory and clinical parameters (24) .
No significant difference in serum neopterin concentration between patients with inflammatory bowel diseases and the control group was found by Forrest et al. It should be emphasized that groups analyzed in this study were very small (5 patients with Crohn's disease and 7 patients with ulcerative colitis) and all patients but one were examined during the remission of the disease (19) .
Other observations were conducted by Propst et al. Authors analyzed the group of 80 patients with IBD (both Crohn's disease and ulcerative colitis) and noted positive correlation between serum neopterin concentration and C-reactive protein, alpha-1-glicoprotein, and IL-1 receptor antagonist in patients with Crohn's disease. Additionally, these parameters correlated with Crohn's disease activity but this was not observed in patients suffering from ulcerative colitis. Obtained results were explained by different etiopathogenesis of both described types of inflammatory bowel diseases (23) .
Significant correlation between neopterin concentration and disease activity was found in other reports concerning patients with ulcerative colitis. It was assessed that neopterin concentration measurement is particularly useful in long-term monitoring of the disease course. Niederwieseret al. observed increased urine neopterin concentration in adults with diagnosed ulcerative colitis in 100% of patients with severe activity of the disease, in 75% with moderate activity and in none of the patients with mild activity of the disease (according to Truelove-Witts score). Usefulness of neopterin concentration measurement was analyzed in relation to commonly assessed clinical parameters, such as: blood hemoglobin level, frequency of stools per day, body temperature, erythrocyte sedimentation rate, the region of inflamed bowel. Correlation between each of these parameters and clinical activity of the disease classified according to Truelove-Witts score was assessed. The strongest correlation was observed with the extent of inflamed bowel and only little less strong correlation was noted for urine neopterin concentration. Erythrocyte sedimentation rate and frequency of stools per day correlated poorer with disease activity, but the weakest correlation was found for body temperature and blood hemoglobin level (11) .
In our study statistically significant positive correlation between serum neopterin concentration and disease activity assessed according to Truelove-Witts score in children with ulcerative colitis was observed.
In conclusion, serum neopterin concentrations can be clinically valuable as the parameter monitoring disease activity in children with ulcerative colitis.
